26 Mar 20

NEWS

Shore Capital acts as Financial Adviser to the TasHeel Group in Arena Events Group £9.5m fundraise

  Arena Events Group plc (AIM: ARE), the international integrated event solutions business, has conditionally raised £9.5 million through a placing of £3.5 million with existing institutional shareholders and a further £6.0 million subscription by the TasHeel Group, a broad

23 Mar 20

NEWS

Shore Capital acts as Nomad and Sole Broker for £6.1m placing for FireAngel

FireAngel (AIM: FA.), one of Europe's leading developers and suppliers of home safety products, announced a proposed open offer to raise approximately £6.1 million, at an issue price of 12 pence per new ordinary share. In addition, approximately £6.1 million (before expenses) condition

29 Feb 20

NEWS

UK Budget must borrow to spend but not increase taxes

Howard Shore, Founder, Shore Capital Group and Puma Brandenburg To spend, or not to spend, that is not the question for Boris Johnson’s first Budget as UK prime minister. That answer was already delivered in December’s general election, where voters voiced emphatic support for higher pu

21 Feb 20

NEWS

Shore Capital is Financial Adviser and Sole Bookrunner on the IPO of Nippon Active Value Fund plc

  First Investment Company IPO of the Decade on the London Stock Exchange            Nippon Active Value Fund (NAVF) has today announced that its shares have been admitted to the Specialist Fund Segment of the London Stock Exchange’s Main Market foll

20 Feb 20

NEWS

Shore Capital acts as Nomad and Sole Bookrunner for US$11.6m (£9.0m) placing for Touchstone Exploration

    Shore Capital is pleased to have acted as Nomad and Sole Bookrunner for Touchstone Exploration Inc. (“Touchstone”) on an issue of common shares that successfully raised US$11.6m (£9.0m). The proceeds of the placing will be used to continue the Company’s exp

12 Feb 20

NEWS

Shore Capital acts as Nomad, Sole Bookrunner and Sole Broker on £5m placing for Sosandar plc

Shore Capital is pleased to have acted as Nomad, Sole Bookrunner and Sole Broker for Sosandar plc (“Sosandar”) on a placing of new ordinary shares that successfully raised £5 million. The ordinary shares were priced at 17p, a 5.6 per cent discount to the closing mid-market price

11 Feb 20

NEWS

Shore Capital acts as Sole Bookrunner on £21.68m Accelerated Bookbuild in ScS

  Shore Capital is pleased to have acted for Parlour Product Holdings on its £21.68m sell-down in ScS Group Plc (ScS), comprising its entire holding of 25.9%. The Placing was conducted through an accelerated bookbuild with Shore Capital acting as sole bookrunner. Parlour Product Holdi

13 Dec 19

NEWS

Howard Shore forecasts business risks for 2020

Appearing on Bloomberg Surveillance on 12 December 2019, Howard Shore discussed the global business outlook going into 2020. He said: "There's always risk out there, it's a question of managing the risk. The risks that we worry about are the risks that we haven't thought about. So it's not

11 Dec 19

NEWS

Shore Capital appointed as Joint Broker to Cpl Resources

Shore Capital is delighted to have been appointed as Joint Broker to Cpl Resources PLC (“Cpl”), Ireland’s leading workforce solutions group with a market capitalisation of £165 million. Cpl is a global provider of talent and workforce solutions with over 13,000 employees a

09 Dec 19

NEWS

Shore Capital appointed as Nomad and Broker to Mpac Group

    Shore Capital is delighted to have been appointed as Nomad and Broker to Mpac Group plc (“Mpac”). Mpac is a global packaging solutions group, delivering ingenious and high-speed packaging solutions to businesses around the world. It has a current market capitalisation

10 Oct 19

NEWS

Shore Capital appointed as Nominated Adviser and Joint Broker to Epwin Group Plc

    Shore Capital is delighted to have been appointed as Nominated Adviser and Joint Broker to Epwin Group Plc (“Epwin”). Epwin is a leading manufacturer of low maintenance, sustainable and energy efficient products to the new build, social housing, DIY, retail and trade s

25 Sep 19

NEWS

Shore Capital acts as Financial Adviser, Nomad and Joint Broker on Amryt Pharma’s acquisition of Aegerion Pharmaceuticals and its $60m fundraise

  Shore Capital is pleased to have acted as Financial Adviser, Nominated Adviser and Joint Broker on Amryt Pharma’s $153m acquisition of Aegerion Pharmaceuticals, Inc. along with a fundraise of $60m in new equity raised from new and existing investors. The acquisition of Aegerion, the

1 2